SUPAC Guidances
- Jeremy Jakob
- Mar 9, 2023
- 1 min read
Updated: Apr 18, 2023

This post contains a list of useful CMC guidance published by FDA SUPAC (Scale Up, Post Approval Changes)
Guidance "SUPAC-MR: Modified Release Solid Oral Dosage Forms Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation" (Link)

Guidance "SUPAC-SS: Nonsterile Semisolid Dosage Forms; Scale-Up and Post-Approval Changes: Chemistry, Manufacturing and Controls; In Vitro Release Testing and In Vivo Bioequivalence Documentation" (Link)

Guidance "SUPAC-IR: Immediate-Release Solid Oral Dosage Forms: Scale-Up and Post-Approval Changes: Chemistry, Manufacturing and Controls, In Vitro Dissolution Testing, and In Vivo Bioequivalence Documentation" (Link)

Guidance "SUPAC: Manufacturing Equipment Addendum" (Link)
